Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome

Trial Profile

Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes; Embolism and thrombosis; Unstable angina pectoris
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
    • 04 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top